RemeGen Co

RemeGen Co Pre-Tax Margin

The Pre-Tax Profit Margin of RemeGen Co (688331.SS) as of Oct 27, 2026 is 21.82 %. In the previous year, Pre-Tax Profit Margin was -85.53 % — a change of -125.51% (higher).

Pre-Tax Margin

21.82 %

YoY

-125.51%

Last updated:

Pre-Tax Profit Margin of RemeGen Co is 2025 21.82 % . Pre-Tax Profit Margin of RemeGen Co was 2024 -85.53 % . It decreases by -125.51% higher compared to the previous year.

The RemeGen Co Pre-Tax Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Pre-Tax Margin
Date
Pre-Tax Margin
Jan 1, 2018
-2,384.49 CNY
Jan 1, 2019
-16,047.44 CNY
Jan 1, 2020
143,673.26 CNY
Jan 1, 2021
19.40 CNY
Jan 1, 2022
-129.36 CNY
Jan 1, 2023
-139.55 CNY
Jan 1, 2024
-85.53 CNY
Jan 1, 2025
21.82 CNY
The RemeGen Co Pre-Tax Margin history
YEARPre-Tax MarginYoY
21.82 %-125.51%
-85.53 %-38.71%
-139.55 %+7.87%
-129.36 %-766.77%
19.40 %-99.99%
143,673.26 %-995.30%
-16,047.44 %+572.99%
-2,384.49 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RemeGen Co Stock analysis

What does RemeGen Co do? RemeGen Co Ltd generates revenue by researching, developing, and manufacturing innovative biopharmaceuticals, specifically focusing on therapeutic antibody drugs. The company's product portfolio includes tetacept (RC18), veldicitumab (RC48), and a dual-target fusion protein (RC28). These products are designed to treat major diseases such as oncology, autoimmune diseases, and ophthalmology. The firm operates primarily in the domestic market within China, where it commercializes its discoveries. Its business model relies on the development of various antibody types, including antibody drug conjugates (ADCs), antibody fusion proteins, monoclonal antibodies, and bispecific antibodies. This focus allows the company to address significant medical needs through its specialized therapeutic offerings. RemeGen Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RemeGen Co stock

Pre-Tax Profit Margin of RemeGen Co is 21.82 % in 2025.

Pre-Tax Profit Margin of RemeGen Co changed from -85.53 % to 21.82 %, representing a -125.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Pre-Tax Profit Margin RemeGen Co since 2006 – with annual values, charts, and detailed analysis.

Pre-tax margin measures the percentage of revenue remaining after all expenses except income taxes. It isolates operational and financial performance from tax effects.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Pre-Tax Profit Margin's RemeGen Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Pre-Tax Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Pre-Tax Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — RemeGen Co

All Key Metrics — RemeGen Co